3.5124
price down icon8.81%   -0.3476
 
loading

Precigen Inc Azioni (PGEN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Income/Loss From Continuing Operations Before Tax
50.81%
-26.64
-54.15 -19.81 -23.97 -60.48
Income Tax Expense/Benefit, Deferred
-
- -0.089 0.012 -1.689
Income Tax Expense/Benefit
0.003
- -0.087 0.012 -1.689
Income/Loss From Continuing Operations After Tax
50.80%
-26.64
-54.15 -19.73 -23.98 -58.79
Net Income/Loss
50.80%
-26.64
-54.15 -19.73 -23.98 -58.79
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.87%
296.43
293.88 8.4727 275.88 252.37
Diluted Average Shares
0.87%
296.43
293.88 8.4727 275.88 252.37
Basic Earnings Per Share
50.00%
-0.09
-0.18 -0.06 -0.09 -0.23
Diluted Earnings Per Share
50.00%
-0.09
-0.18 -0.06 -0.09 -0.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$34.92
price down icon 2.39%
$81.44
price down icon 3.18%
$28.68
price down icon 2.58%
$97.88
price down icon 1.88%
$135.83
price down icon 3.62%
biotechnology ONC
$327.37
price down icon 0.64%
Capitalizzazione:     |  Volume (24 ore):